Expedition Therapeutics Funding: $165M Raised, Series A
Expedition Therapeutics is a Biotech company based in San Francisco. It has raised $165M in total funding. Latest round: Series A.
Expedition Therapeutics funding overview
Expedition Therapeutics is a Biotech company based in San Francisco. Expedition Therapeutics has raised $165M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2025. The round record for Expedition Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Venrock, BVF Partners, Lake Bleu Capital, Sofinnova Investments, Novo Holdings, Forbion and 3 others. 9 distinct backers are named across the disclosed rounds.
Expedition Therapeutics at a glance
Total raised
$165M
Latest round
Series A
Latest round date
October 2025
Industry
Biotech
Headquarters
San Francisco
Notable investors
Venrock, BVF Partners, Lake Bleu Capital, Sofinnova Investments, Novo Holdings, Forbion, Dawn Biopharma, Adage Capital
Frequently asked about Expedition Therapeutics funding
How much has Expedition Therapeutics raised?
Expedition Therapeutics has raised $165M in total disclosed funding across the rounds on record.
Who has invested in Expedition Therapeutics?
Venrock, BVF Partners, Lake Bleu Capital, Sofinnova Investments, Novo Holdings, Forbion are named among the investors backing Expedition Therapeutics.
What was the latest Expedition Therapeutics funding round?
The most recent disclosed round is a Series A, announced in October 2025.
Where is Expedition Therapeutics based?
Expedition Therapeutics is based in San Francisco.
What sector does Expedition Therapeutics operate in?
Expedition Therapeutics is tracked under Biotech from San Francisco, with $165M in disclosed funding.
When did Expedition Therapeutics last raise?
The last disclosed Expedition Therapeutics round closed in October 2025 at Series A.
Expedition Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in San Francisco below to benchmark round size and investor mix.
